Cite

HARVARD Citation

    Luo, F. et al. (2019). Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record